• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MSB
Click for more information
0.56% 90.5¢

MESOBLAST LIMITED - Corporate Spotlight

Market Cap $1.033B  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Mesoblast Limited is an Australia-based is developing a range of late-stage product... Mesoblast Limited is an Australia-based is developing a range of late-stage product candidates derived from its proprietary mesenchymal lineage cell therapy technology platforms. The Company’s Remestemcel-L is mesenchymal lineage stromal cell product platform and is in late-stage development for treatment of systemic inflammatory diseases, including Pediatric steroid refractory acute Graft versus Host Disease (SR-aGVHD), acute respiratory distress syndrome (ARDS) and Biologic refractory inflammatory bowel disease. Its Rexlemestrocel-L is mesenchymal lineage precursor cell product platform and is in late-stage development for treatment of advanced chronic heart failure (CHF) and chronic low back pain (CLBP) due to degenerative disc disease. Two products are commercialized in Japan and Europe by the Company’s licensees, and it has a commercial partnership in Europe and China for certain Phase III assets.More

No Corporate Spotlight currently available.

(20min delay)
Last
90.5¢ 		Change
0.005(0.56%) 		Mkt cap ! $1.033B
Open High Low Value Volume
92.0¢ 93.5¢ 89.0¢ $4.255M 4.660M

Buyers (Bids)

No. Vol. Price($)
18 47893 90.5¢
 

Sellers (Offers)

Price($) Vol. No.
91.0¢ 49661 15
View Market Depth
Last trade - 13.18pm 24/04/2024 (20 minute delay) ?
Last
91.0¢ 		  Change
0.005 ( 0.89 %)
Open High Low Volume
91.0¢ 93.5¢ 89.0¢ 1209182
Last updated 13.35pm 24/04/2024 ?
MSB (ASX) Chart

Top Stories

High grade sniffs in Africa push Mako shares up 14%

Mako Gold Ltd (ASX: MKG) has seen its shares jump above 14 percent on news that it has discovered a high grade zone with grades of 76 grams per tonne at its 868,000-ounce Napié Project in Côte d’Ivoire.Shares rose 14.28 percent to 16 cents on Wednesday, as the exploration company ...
Unith wraps up Q1 with $5M in cash as digital humans evolve Unith has wrapped up Q1 of 2024 with nearly $5M in cash and opex reduced. But the bigger story is how good its digital humans are getting.
AML3D secures Australian defence government contract AML3D signed a contract with the Australian Government Defence Science and Technology Group (DSTG) to supply components for marine defence
PharmAust CEO's sayanora triggers stock plunge Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn.
Lithium Universe eyes hydropower setup for greener battery metals Lithium Universe announced it has made an application in Canada for renewable electricity to power its lithium carbonate plant.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.